$1.420
-0.067 (-4.70%)Zum Schluss
CRIS im Vergleich zur Peergroup
In the context of the broader market, CRIS competes directly with industry leaders such as BCAB and CHGA. With a market capitalization of $4.37M, it holds a leading position in the sector. When comparing efficiency, CRIS's gross margin of N/A stands against BCAB's 100.00% and CHGA's N/A. Such benchmarking helps identify whether Curis Inc is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Curis Inc
Curis reported total revenue of $2.93 million in Q3 2024, but faced a net loss of $24.2 million in Q1 2026, reflecting ongoing financial challenges. Despite this, the gross margin was exceptionally high at 104.37% in Q3 2024, indicating strong product profitability when operational issues are resolved.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.